John R. J. Sorenson
Division of Medicinal Chemistry
Department of Pharmaceutical Sciences
College of Pharmacy #522-3
University of Arkansas
USA
Name/email consistency: high
- Co-treatment with copper compounds dramatically decreases toxicities observed with cisplatin cancer therapy and the anticancer efficacy of some copper chelates supports the conclusion that copper chelate therapy may be markedly more effective and less toxic than cisplatin therapy. Sorenson, J.R., Wangila, G.W. Curr. Med. Chem. (2007)
- Cu, Fe, Mn, and Zn chelates offer a medicinal chemistry approach to overcoming radiation injury. Sorenson, J.R. Curr. Med. Chem. (2002)
- Prion diseases: copper deficiency states associated with impaired nitrogen monoxide or carbon monoxide transduction and translocation. Sorenson, J.R. J. Inorg. Biochem. (2001)